If some or all of the phase trials perform well, this will be a major long term win. There will be peaks and valleys along the way in stock price. Contrary to what many paranoid posters post here, nothing bad or good that posters post will make any substantial difference in the long term or short term price. Big money is at play here and they will dominate the price fluctuations. However, it is my belief that their goal is to drive the long term price way higher and control accumulation at these lower prices.
I'm of the mind that the turning point is the PII HPV data. If the unblinded results are great, then all of INO's pipeline is validated and the rush will be on to get in on the bio-goldmind. If not, then the rush will be toward the exits.
Speculation at best, but if they continue to provide positive results, and given the fairly large share count 15 to 20. Trying to predict time and price probably is unrealistic in terms of accuracy, I would guess what I just posted will be off by a factor of 3 in either direction.